Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy (Q34964783)
scientific article
Language:
(P31) (Q13442814)
(P304) 571-576
(P407) (Q1860)
(P433) 2
(P478) 97
(P577) Saturday, January 1, 2000
(P921) (Q372016)
(Q60728774)
(Q11085)
(Q24767155)
(Q11376)
(P1433) (Q1146531)
(P1476) "Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy" (language: en)
(P2093) K A Conway
S J Lee
J C Rochet
T T Ding
R E Williamson
P T Lansbury
(P2860) (Q33723502)
(Q28138668)
(Q33678168)
(Q41676981)
(Q22009563)
(Q35134776)
(Q33546211)
(Q40964871)
(Q52534341)
(Q28610102)
(Q47852610)
(Q24653247)
(Q29547593)
(Q35764504)
(Q29547175)
(Q48557845)
(Q41680091)
(Q41550219)
(Q27860459)
(Q35765360)
(Q36830682)
(Q41095404)
(Q40918121)
(Q28610089)
(Q36385621)
(Q54131245)
(Q48149673)
(Q48157079)
(Q48199591)
(Q48327140)
(Q48353748)
(Q48384247)
(Q53218877)
(Q45294913)
(Q78177648)
(Q67234310)
(Q73431442)
(Q64862724)
(Q64865964)
(Q64865343)
other details
aliases Acceleration of oligomerization, not fibrillization, is a shared property of both alpha -synuclein mutations linked to early-onset Parkinson's disease: Implications for pathogenesis and therapy
description scientific article

External Links